These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7233887)

  • 21. [Carriers of HBs antigen, anti-HIV antibodies and their association with blood donors in Brazzaville].
    Yala F; Olembe C; M'Pelé P; Rosenheim M
    Bull Soc Pathol Exot Filiales; 1988; 81(1):32-9. PubMed ID: 3165308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serological profiles of hepatitis B carrier patients in Singapore with special reference to the frequency and significance of concurrent presence of HBsAg and anti-HBs.
    Wang YM; Ng WC; Kang JY; Yap I; Seet BL; Teo J; Smith R; Guan R
    Singapore Med J; 1996 Apr; 37(2):150-2. PubMed ID: 8942251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of IgG subclass profiles of anti-HBs in populations with different HBV infection status.
    Tsai TH; Huang CF; Wei JC; Ho MS; Wang L; Tsai WY; Lin CC; Xu FL; Yang CC
    Viral Immunol; 2006; 19(2):277-84. PubMed ID: 16817770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe.
    Bonino F; Rosina F; Rizzetto M; Rizzi R; Chiaberge E; Tardanico R; Callea F; Verme G
    Gastroenterology; 1986 May; 90(5 Pt 1):1268-73. PubMed ID: 3956945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hepatitis B viral markers in the liver tissue of HBs-antigen carriers].
    Mansurov KhKh; Mirodzhov GK; Tkalicheva LI
    Arkh Patol; 1984; 46(4):46-51. PubMed ID: 6375639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of maternal carrier status on immunologic markers for protection after hepatitis B vaccination in infancy: a meta-analysis.
    Schönberger K; Riedel C; Rückinger S; Mansmann U; Jilg W; von Kries R
    Vaccine; 2012 Sep; 30(44):6314-26. PubMed ID: 22885275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The "e" antigen system in HBs antigen carriers (author's transl)].
    Schnell P; Courouce AM; Opolon P; Darnis F
    Nouv Presse Med; 1978 Oct; 7(35):3105-8. PubMed ID: 103075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Some remarks of HBsAg and anti-HBs distribution in symptom-free carriers.
    Sabău M; Mosley JW; Demeter S
    Arch Roum Pathol Exp Microbiol; 1977; 36(3-4):255-61. PubMed ID: 617040
    [No Abstract]   [Full Text] [Related]  

  • 29. Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers.
    Dusheiko GM; Hoofnagle JH; Cooksley WG; James SP; Jones EA
    J Clin Invest; 1983 May; 71(5):1104-13. PubMed ID: 6602149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [An experience of the use of Anti-HBc and Anti-HBs for blood donor screening tests at a tertiary hospital blood center in Korea].
    Lim YA; Yoon S
    Korean J Lab Med; 2009 Feb; 29(1):59-65. PubMed ID: 19262080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [HBeAg and anti-HBe levels in HBsAg positive blood donors].
    Hasçelik G; Günalp A
    Mikrobiyol Bul; 1989 Jan; 23(1):23-9. PubMed ID: 2626096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of antibody to the hepatitis delta virus in symptomless HBsAg carriers.
    Arico S; Aragona M; Rizzetto M; Caredda F; Zanetti A; Marinucci G; Diana S; Farci P; Arnone M; Caporaso N
    Lancet; 1985 Aug; 2(8451):356-8. PubMed ID: 2862515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of tests for HBeAg and anti-HBe in HBsAg positive blood donors.
    Dow BC; Macvarish I; Barr A; Crawford RJ; Mitchell R
    J Clin Pathol; 1980 Nov; 33(11):1106-9. PubMed ID: 7440758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antigens and antibodies in acute viral hepatitis caused by the B virus. Clinical significance].
    Malacco E; Iacono G; Risso F
    Minerva Med; 1979 Feb; 70(6):479-82. PubMed ID: 431867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis].
    Kalinowska B; Nazarewicz-de Mezer T; Krawczyński K
    Przegl Epidemiol; 1984; 38(3):249-56. PubMed ID: 6528039
    [No Abstract]   [Full Text] [Related]  

  • 36. The natural history of asymptomatic hepatitis B surface antigen carriers.
    de Franchis R; Meucci G; Vecchi M; Tatarella M; Colombo M; Del Ninno E; Rumi MG; Donato MF; Ronchi G
    Ann Intern Med; 1993 Feb; 118(3):191-4. PubMed ID: 8417636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hepatitis B virus epidemiology: degree of contamination and hyperreactors].
    Pfenninger-Schaer K; Frey-Wettstein M; Grob PJ
    Schweiz Med Wochenschr; 1982 Apr; 112(14):478-82. PubMed ID: 7079683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serological markers of hepatitis B virus infection in healthy volunteer blood donors in Campania (Southern Italy).
    Ascione A; Forte GB; Amitrano L; De Bellis G; Pandolfi C; Iaccarino L; Mariconda M; Petringa D; Utech W; Vacca C
    Vox Sang; 1981 Sep; 41(3):146-50. PubMed ID: 7331288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of hepatitis B virus markers among Ethiopian blood donors: is HBsAg screening necessary?
    Tsega E; Mengesha B; Nordenfelt E; Hansson BG; Lindberg J
    Trop Geogr Med; 1987 Oct; 39(4):336-40. PubMed ID: 3451408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Occurrence of HBs antigen and anti-HBs antibodies in analytical laboratory workers in Warsaw].
    Sośnierz L
    Pol Tyg Lek; 1989 Apr; 44(17):383-6. PubMed ID: 2626358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.